Revenue

The home care franchise expands to the Golden State, targeting a massive aging population while navigating a complex market and regulatory landscape.

The rail supplier's stellar Q2 results point to surprising strength in coal, rail, and tunneling, but rising costs reveal the challenges of rapid growth.

A new AI platform promises to fix billions in revenue loss from complex cardiac coding, but will it empower or replace human experts in the process?

A new peer-reviewed study shows Glucotrack's fully implantable glucose monitor is accurate for 240 days, a key step towards a 3-year, no-wearable future.

Medtech titan Brad Saar joins Sonablate's board, signaling a major push to make non-invasive HIFU a global standard for prostate cancer treatment.

The memory chip maker secures a major defense contract, highlighting the critical role of its MRAM tech and U.S.-based manufacturing for national security.

The expanded partnership integrates real-time case tracking and post-sale servicing into Hexure's FireLight, aiming to create a single, unified workflow.

Singapore's TechCreate reports 54% revenue growth and a quantum tech leap, but a regulatory trading halt has left investors and the market in the dark.

A new collaboration leverages a vast cord blood bank and advanced AI to create off-the-shelf cell therapies, promising a new era in regenerative medicine.

Documo’s award-winning AI platform is turning the tide on healthcare's reliance on fax, automating paperwork to reduce staff burnout and improve patient care.

Alkeus Pharmaceuticals will present crucial data on its oral drug for Stargardt disease, a leading cause of juvenile blindness with no current cure.

The Jewish Theological Seminary appoints engagement expert Rabbi Mike Uram, signaling a strategic shift to modernize and expand its reach in a changing world.

BsStrategy's latest platform update signals a major shift in AI finance, where robust infrastructure and risk control are eclipsing the hunt for magic algorithms.

PVP Labs' new drug offers potent pain relief without addiction risk. A landmark DEA ruling clears it as a non-controlled substance, set to reshape medicine.

The logistics firm's recognition as a climate leader highlights an industry race where sustainability is now a key competitive and strategic advantage.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

A new partnership delivers a domestically-made BESS control system, tackling strict federal regulations and securing the US clean energy supply chain.

A $1M donation marks a quarter-century partnership between Kohl's and Children's Wisconsin, funding a crucial fight against the state's youth mental health crisis.

A strategic merger between Tenet’s AI platform and Crown’s air freight legacy aims to create a unified, end-to-end solution for North American carriers.

A Boston biotech is using AI and targeted mRNA to program cells inside the body, aiming to make complex CAR T treatments safer and universally accessible.